Contraceptive Efficacy and Safety of NOMAC-E2 Combined Oral Contraceptive
Status:
Recruiting
Trial end date:
2024-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is evaluating Contraceptive Efficacy and Safety of NOMAC-E2
Combined Oral Contraceptive in Premenopausal Females Aged 14 to 35 Years (Inclusive).